Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Gerstner

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Journal of Neuro-Oncology|March 1, 2021
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastomaMary Jane Lim-Fat, Kun Wei Song, J Bryan Iorgulescu, et al.
Neurology|January 30, 2024
Discontinuation of Antiseizure Medications in Patients With Brain TumorsKatherine B Peters, Jessica Templer, Elizabeth R Gerstner, et al.
The Oncologist|December 7, 2013
Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiationMarco C Pinho, Pavlina Polaskova, Jayashree Kalpathy-Cramer, et al.
Radiology. Artificial Intelligence|April 12, 2021
Radiomics Repeatability Pitfalls in a Scan-Rescan MRI Study of GlioblastomaKatharina V Hoebel, Jay B Patel, Andrew L Beers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2016
Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant GliomaWilliam T Curry, Ramana Gorrepati, Matthias Piesche, et al.
Breast Cancer Research and Treatment|September 22, 2019
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastasesJosé Pablo Leone, Dan G Duda, Jiani Hu, et al.
Neuro-Oncology|October 21, 2020
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymomaMark R Gilbert, Ying Yuan, Jimin Wu, et al.
Journal of Neuro-Oncology|December 16, 2014
Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort studyMilan G Chheda, Patrick Y Wen, Fred H Hochberg, et al.
Translational Oncology|June 10, 2015
Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma PatientsKourosh Jafari-Khouzani, Kyrre E Emblem, Jayashree Kalpathy-Cramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2015
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-HydroxyglutarateOvidiu C Andronesi, Franziska Loebel, Wolfgang Bogner, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Journal of Neuro-Oncology|March 1, 2021
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastomaMary Jane Lim-Fat, Kun Wei Song, J Bryan Iorgulescu, et al.
Neurology|January 30, 2024
Discontinuation of Antiseizure Medications in Patients With Brain TumorsKatherine B Peters, Jessica Templer, Elizabeth R Gerstner, et al.
The Oncologist|December 7, 2013
Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiationMarco C Pinho, Pavlina Polaskova, Jayashree Kalpathy-Cramer, et al.
Radiology. Artificial Intelligence|April 12, 2021
Radiomics Repeatability Pitfalls in a Scan-Rescan MRI Study of GlioblastomaKatharina V Hoebel, Jay B Patel, Andrew L Beers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2016
Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant GliomaWilliam T Curry, Ramana Gorrepati, Matthias Piesche, et al.
Breast Cancer Research and Treatment|September 22, 2019
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastasesJosé Pablo Leone, Dan G Duda, Jiani Hu, et al.
Neuro-Oncology|October 21, 2020
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymomaMark R Gilbert, Ying Yuan, Jimin Wu, et al.
Journal of Neuro-Oncology|December 16, 2014
Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort studyMilan G Chheda, Patrick Y Wen, Fred H Hochberg, et al.
Translational Oncology|June 10, 2015
Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma PatientsKourosh Jafari-Khouzani, Kyrre E Emblem, Jayashree Kalpathy-Cramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2015
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-HydroxyglutarateOvidiu C Andronesi, Franziska Loebel, Wolfgang Bogner, et al.
Pageof 14